Xiao-Song Gong

This inventor holds 18 USPTO granted patents, plus 3 CIPO patents and 8 EPO patents, primarily in RNA Amplification. Top assignee: Bio-Rad Laboratories, Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao-Song Gong. Retrieved from https://idiyas.com/inventor/xiao-song-gong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 77.8

CIPO Patents = 3

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 88(Granted Patents)

Location History:

Berkeley, CA (US) (2012 - 2020)
Richmond, CA (US) (2016 - 2023)
Hercules, CA (US) (2021 - 2024)

Company Filing History:

18 out of 1,072

Bio-Rad Laboratories, Inc.

patents

Years Active: 2012-2024

Loading Chart...

Areas of Expertise:

Reverse Transcriptases

RNA Amplification

Nucleic Acids

RT-PCR

Dimeric Reverse Transcriptase

Storage Stability

Efficiency Improvement

Buffers

Compositions

Inhibition Reduction

Stabilized RNA Solutions

Amplification Methods

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065645 - Reverse transcriptases and uses thereof (2024-08-20),

2. 11834685 - Dimeric reverse transcriptase (2023-12-05),

3. 11649453 - Reverse transcriptases and uses thereof (2023-05-16),

4. 11021735 - RNA amplification methods (2021-06-01),

5. 11021693 - Dimeric reverse transcriptase (2021-06-01),

6. 10988762 - Reverse transcriptases and uses thereof (2021-04-27),

7. 10787694 - Methods and compositions for improving efficiency of nucleic acids amplification reactions (2020-09-29),

8. 10364420 - Dimeric reverse transcriptase (2019-07-30),

9. 10351840 - Reverse transcriptase mixtures with improved storage stability (2019-07-16),

10. 10301675 - Compositions and methods for reducing inhibition of RT-PCR (2019-05-28),

11. 10131898 - Buffers for use with polymerases (2018-11-20),

12. 10072285 - RNA amplification methods (2018-09-11),

13. 9994887 - Methods and compositions for improving efficiency of nucleic acids amplification reactions (2018-06-12),

14. 9896682 - Stabilized RNA solutions (2018-02-20),

15. 9458484 - Reverse transcriptase mixtures with improved storage stability (2016-10-04),

Title: The Innovative Contributions of Inventor Xiao-Song Gong

Introduction

Xiao-Song Gong is a distinguished inventor based in Richmond, California, recognized for his significant contributions to the field of biotechnology. With a total of 18 patents to his name, Gong has made notable advancements, particularly in the development of reverse transcriptases.

Latest Patents

Among Xiao-Song Gong's latest patents are innovative creations such as "Reverse transcriptases and uses thereof," which introduces hybrid reverse transcriptases formed from portions of FLVRT and MLVRT. Another significant patent is "Dimeric reverse transcriptase," which elaborates on covalently-linked DNA polymerases, showcasing Gong's expertise and creativity in the domain of molecular biology.

Career Highlights

Gong is currently affiliated with Bio-Rad Laboratories, Inc., a global leader in life sciences research and clinical diagnostics. His position at such a renowned company underscores his reputation in the industry and highlights his commitment to advancing scientific understanding and technology.

Collaborations

Throughout his career, Xiao-Song Gong has collaborated with prominent colleagues, including Yan Wang and her coworker Man Cheng. These partnerships have been instrumental in the development of groundbreaking technologies and solutions in their research initiatives.

Conclusion

In conclusion, inventor Xiao-Song Gong's contributions in the field of reverse transcriptases exemplify his dedication to innovation and research. With a strong portfolio of patents and fruitful collaborations, Gong continues to influence the biotechnology sector significantly, helping to pave the way for future scientific advancements.

Profile summary based on public USPTO records.